血清类固醇谱在肾上腺皮质癌诊断中的前瞻性队列研究
该前瞻性单中心队列研究纳入2015至2023年263例肾上腺肿块患者,采用液相色谱-质谱法检测血清11-脱氧皮质醇、17OH-孕酮和17OH-孕烯醇酮,评估其诊断肾上腺皮质癌(ACC)的准确性。局部广义矩阵学习向量量化分析构建的血清类固醇评分鉴别ACC与非ACC的受试者工作特征曲线下面积均值为0.823。作者认为这些指标对诊断ACC可能有价值,血清类固醇评分经适当验证后可整合入临床实践。
要点
- 263例肾上腺肿块患者中44例(16.7%)诊断为ACC,161例(61%)为肾上腺皮质腺瘤(ACA)。
- ACC患者三种血清类固醇均高于非ACC患者,包括与功能性ACA及CT值≥20的ACA比较(P均<0.0001)。
- 血清类固醇评分鉴别ACC与非ACC的受试者工作特征曲线下面积均值为0.823。
核心结论
- 检测11-脱氧皮质醇、17OH-孕酮和17OH-孕烯醇酮可能对诊断ACC有价值。
- 作者认为血清类固醇评分经适当验证后可整合入临床实践。
研究设计与样本
- 前瞻性单中心队列研究,纳入2015年至2023年评估的肾上腺肿块患者263例。
- 采用液相色谱-质谱法检测血清17OH-孕烯醇酮、17OH-孕酮和11-脱氧皮质醇。
- 肾上腺肿块参考标准包括组织病理学、影像学特征、2年影像学随访或5年临床随访。
- 采用局部广义矩阵学习向量量化分析构建血清类固醇评分,并以受试者工作特征曲线下面积评估。
主要发现
- 263例肾上腺肿块患者中,44例(16.7%)诊断为ACC,161例(61%)为ACA,27例(10%)为其他肾上腺恶性肿瘤,31例(12%)为其他。
- 所有ACC、除1例外的其他肾上腺恶性肿瘤以及58例(31%)ACA显示CT值≥20。
- ACC患者三种血清类固醇均高于非ACC患者,包括与功能性ACA比较及与CT值≥20的ACA比较(P均<0.0001)。
- 血清类固醇评分鉴别ACC与非ACC的受试者工作特征曲线下面积均值为0.823。
关键数值与推荐
- 指南建议对肾上腺肿瘤性质未定的患者进行尿类固醇谱分析,以无创诊断ACC。
- 尿类固醇谱分析并未广泛可及。
临床怎么用
- 作者认为血清类固醇评分经适当验证后可整合入临床实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Guidelines suggest performing urine steroid profiling in patients with indeterminate adrenal tumors to make a noninvasive diagnosis of adrenocortical carcinoma (ACC). However, urine steroid profiling is not widely available. OBJECTIVE: To determine the accuracy of clinically available serum 11-deoxycortisol, 17OH-progesterone, and 17OH-pregnenolone in diagnosing ACC. METHODS: We conducted a prospective single-center cohort study of patients with adrenal masses evaluated between 2015 and 2023. Serum was analyzed by liquid chromatography-mass spectrometry for 17OH-pregnenolone, 17OH-progesterone, and 11-deoxycortisol. Reference standard for adrenal mass included histopathology, imaging characteristics, imaging follow up of 2 years, or clinical follow up of 5 years. Localized Generalized Matrix Learning Vector Quantization analysis was used to develop serum steroid score and assessed with area under receiver operating curve. RESULTS: Of 263 patients with adrenal masses, 44 (16.7%) were diagnosed with ACC, 161 (61%) with adrenocortical adenomas (ACAs), 27 (10%) with other adrenal malignancies, and 31 (12%) with other. Hounsfield unit ≥ 20 was demonstrated in all ACCs, in all but 1 other adrenal malignancy, and in 58 (31%) ACAs. All 3 steroids were higher in patients with ACCs vs non-ACCs, including when comparing ACCs with functioning ACAs, and with ACAs with Hounsfield unit ≥ 20 (P < .0001 for all). Localized Generalized Matrix Learning Vector Quantization analysis yielded a serum steroid score that discriminated between ACC and non-ACC groups with a mean threshold fixed area under receiver operating curve of 0.823. CONCLUSION: We showed that measurements of 11-deoxycortisol, 17OH-progesterone, and 17OH-pregnenolone could be valuable in diagnosing ACC. After appropriate validation, serum steroid score could be integrated in clinical practice.
引用
- Yu K, Athimulam S, Saini J, et al. Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study. J Clin Endocrinol Metab. 2025. PMID: 39231247. doi:10.1210/clinem/dgae604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。